New Developments / See All

@Science4Brazil

Brazil's marketers branding agroindustrial exports as "hi-tech and sophisticated" yet they degrade environment and… https://t.co/e9SkVyLFqw
- Tuesday Jan 16 - 11:13am

Brazil's outlier University of São Paulo may have dropped to 250-300 in THE's World University rankings, but it's s… https://t.co/ieZnJYHqVp
- Tuesday Jan 16 - 11:03am

Let's hear it for the Latino allotment movement. If European gardeners can make greener cities, why not La Paz, Bs… https://t.co/vNJo8tmWDW
- Tuesday Jan 16 - 9:36am

Should you measure a country's innovation by its number of patents, the number of scientific papers produced or… https://t.co/ci0iMqOhD1
- Monday Jan 15 - 10:20am

"Surfer superfood" Açaí from Brazilian Amazon was carrier of deadly Chagas sleeping sickness.https://t.co/OYLr8xk6sA
- Sunday Jan 14 - 8:20am

Does Brazil hold keys to global “Plant Plague”?

Brazilian oranges affected by CVC citrus  blight  could hold  keys of Europe's olive leaf scorch.

A sinister plant disease with the power to destroy farmers’ livelihoods named “the Ebola of olive trees”  is on the march across Europe during 2018; yet the same bacteria could for decades have been affecting coffee plantations, orange groves and other high value crops in Latin America. In fact some of the science now needed   …Continue Reading

Biopiracy fear incites Pharma “Dutch Disease”

"Drogas do Sertão" were precursors of medical trade

It’s been half a millennium since European visitors first came to Brazil, in pursuit of its mineral and agricultural riches. Jesuit missionaries also discovered huge wealth in the “drogas do sertão” or back-country remedies such as sarsaparilla, guaraná, or urucum, all widely used in early medicine. Fears that foreign “biopirates” were stealing these riches –   …Continue Reading

Scientist puts venture capitalists under microscope

Call for transparency:  Brazil's Venture Capital industry  goes under  the microscope. Photo Creative  Commons.

Private Equity Bay (Pebay): It’s normal for scientific research and business to inhabit parallel but quite distinct worlds, with investors only showing much interest in innovators once they’ve developed marketable products. Many a would-be scientist entrepreneur has waited nervously for a venture capitalist to “run the slide rule” over his or her ideas. But now   …Continue Reading